Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
The MarketWatch News Department was not involved in the creation of this content. WILMINGTON, Del., Sep 29, 2020 (GLOBE NEWSWIRE...
